Alvesco — Medica
eosinophilic esophagitis
Preferred products
- Qvar RediHaler
Initial criteria
- If the patient has tried one Preferred Product (Qvar RediHaler), approve a Non-Preferred Product
- If the patient is being treated for eosinophilic esophagitis, approve Flovent HFA
Approval duration
1 year